Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BChE-IN-13 (Compound 17c) is an orally active, potent, and selective inhibitor of Butyrylcholinesterase (BChE). It exhibits IC50 values of 0.22 μM and 0.016 μM for eqBChE and hBChE, respectively. BChE-IN-13 demonstrates the capability to enhance memory and cognitive impairments, making it valuable for Alzheimer's disease (AD) research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | BChE-IN-13 (Compound 17c) is an orally active, potent, and selective inhibitor of Butyrylcholinesterase (BChE). It exhibits IC50 values of 0.22 μM and 0.016 μM for eqBChE and hBChE, respectively. BChE-IN-13 demonstrates the capability to enhance memory and cognitive impairments, making it valuable for Alzheimer's disease (AD) research [1]. |
In vitro | BChE-IN-13, administered at concentrations ranging from 5-100 μM over a 24-hour period, demonstrates minimal toxicity towards SH-SY5Y, PC-12, and HT-22 cells, maintaining over 60% viability even at the highest concentration. Conversely, it significantly affects BV2 cells, with a noteworthy mortality rate that reaches 50% at a concentration of 20 μM. Furthermore, BChE-IN-13 exhibits excellent penetration through the blood-brain barrier, as evidenced by its performance in Parallel Artificial Membrane Permeability Assay (PAMPA) experiments. This dual activity profile highlights its potential for selective application in neurological contexts. |
In vivo | BChE-IN-13, administered through oral gavage at a dosage of 15 mg/kg once daily for 6 days, enhances memory and cognitive functions in mice exhibiting Alzheimer's disease-like symptoms induced by Aβ 1-42 [1]. In this study, ICR mice were intracerebroventricularly injected with oligomerized Aβ 1-42 to model the disorder. The observed improvement in cognitive performance and memory, evidenced by reduced latency, was more significant compared to the effect seen with Donepezil. |
Molecular Weight | 360.49 |
Formula | C24H28N2O |
CAS No. | 2700896-73-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BChE-IN-13 2700896-73-5 inhibitor inhibit